An Improved Detection of Circulating Tumor DNA in Extracellular Vesicles-Depleted Plasma

Circulating tumor DNA (ctDNA) in plasma has been used as a biomarker for cancer detection and outcome prediction. In this study, we collected the five precipitates (fractions 1–5) and leftover supernatant plasma component (fraction 6) by a sequential centrifugation in plasma samples from nine small...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Li, Du, Meijun, Kohli, Manish, Huang, Chiang-Ching, Chen, Xiaoxiang, Xu, Mu, Shen, Hongbing, Wang, Shukui, Wang, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226168/
https://www.ncbi.nlm.nih.gov/pubmed/34178690
http://dx.doi.org/10.3389/fonc.2021.691798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226168/
https://www.ncbi.nlm.nih.gov/pubmed/34178690
http://dx.doi.org/10.3389/fonc.2021.691798

Ejemplares similares